Humasis takes out US patent
2015-11-30

2012-02-22 10:00:03

Humasis takes out US patent

Humasis Co., Ltd, has taken out US patent, “a diagnostic device for measuring the ratio of similar structural proteins” on January 24th, 2012. (Patent No. US8, 101,369 B2)

The present invention relates to a diagnostic device for measuring the ratio of similar structural proteins among the proteins secreted in a liquid test sample taken from diagnosis subject. In further detail, the test device according to the present invention comprises detection marker-antibody conjugate recognizing the same site on two or more similar structural proteins and a detection zone in which antibody specifically recognizes each of said proteins via formation of sandwich type complex, wherein said antibodies form a set.

Humasis completed the development of the products which adopt the patent, which are diagnostic devices for early diagnosis of polycystic ovary syndrome (HUBI-PSCOScreen), abnormal pregnancy (Inexscreen) and prostatic carcinoma (HUBI-BPScreen).

The acquisition of US patent proves Humasis’ technology and we, Humasis Co., Ltd., will strive to research and develop more diagnostic device and to export the technology based on current patent.